It is known that HER2 is overexpressed in poorly differentiated DCIS in approximately 42% of the cases [7], and it has been suggested that HER2 overexpression is an early step in the evolution of a distinct type of breast carcinoma. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.